Pharma in Healthcare
Pharma in Healthcare
IBSA foundation fellowships shatter records with unprecedented global reach and opens 2026 call
IBSA Foundation (Institut Biochimique SA) for scientific research, recently announced a record-shattering year for its prestigious fellowship programme, drawing an unprecedented 398 applications from 64 countries....
Pharma in Healthcare
Acute myocardial infarction market is expected to hit growth stride at a CAGR of 13% during the forecast period (2026-2036) with new therapeutic innovations
Recently published acute myocardial infarction market insights report includes a comprehensive understanding of current treatment practices, acute myocardial infarction emerging drugs, market share of...
Pharma in Healthcare
Charcot-Marie-Tooth disease market growth to accelerate significantly during the forecast period (2026-2036) driven by the launch of emerging disease-modifying therapies
Recently published Charcot–Marie–Tooth Disease Market Insights report includes a comprehensive understanding of current treatment practices, Charcot–Marie–Tooth disease emerging drugs, market share of individual therapies,...
Pharma in Healthcare
Tyra Biosciences and the Bladder Cancer Advocacy Network have established 21 May as upper tract urothelial cancer awareness day
Tyra Biosciences has announced the establishment of Upper Tract Urothelial Cancer (UTUC) Awareness Day, in collaboration with the Bladder Cancer Advocacy Network (BCAN).
UTUC is...
Pharma in Healthcare
Valion Bio briefs senior Department of War and BARDA officials in joint engagement on Entolimod for acute radiation syndrome
Valion Bio, a late-stage innate immunotherapeutics company, has announced that it presented Entolimod for acute radiation syndrome (ARS) to senior officials from the US Department...
Pharma in Healthcare
Global Alzheimer’s therapeutics market expands at 9.3% CAGR as biologics and early diagnosis transform dementia care
The global Alzheimer's therapeutics market is projected to grow from US$ 4.3 billion in 2026 to US$ 10.4 billion by 2036, expanding at a CAGR of 9.3% during the forecast...
Pharma in Healthcare
Marty Makary resigns as chief of the Food and Drug Administration
Marty Makary, US Food and Drug Administration (FDA) commissioner, is leaving his post, US president Donald Trump said yesterday Tuesday 12 May 2026.
Mr Trump...
Drug Discovery & Development
US$ 8.5 million investment in malaria and other R&D projects planned among pharma giants
The global health innovative technology (GHIT) fund has announced a total investment of approximately JPY 1.37 billion (US$ 8.5 million) in five R&D projects...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Latest stories
© 2026 Pharma Press Publishing.